iVeena
Barry Hanover was the CEO of iVeena from January 2015 to December 2015. Barry is currently the Director at iVeena.
This person is not in the org chart
This person is not in any offices
iVeena
Keratoconus, progressive myopia, and development of cystoid macular edema are areas of major unmet medical need. iVeena is developing two platform technologies in cornea and cataract — including topical delivery of copper and drug delivery from the lens capsule respectively. These novel approaches provide impactful and minimally invasive solutions for patients and physicians.